Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance
- PMID: 22755416
Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance
Abstract
Objective: We analyzed a single center's experience during 16 years of living-donor liver transplantation (LDLT). The impacts of HLA mismatches and positive crossmatches on long term outcomes and tolerance were evaluated.
Methods: This study was of primary LDLTs of consecutive patients from January 1996 to December 2011; re-transplants were not included. Long-term survival was compared by primary disease, number of HLA mismatches, and crossmatches. Demographics and complications after transplantation between pediatric recipients who achieved clinical operational tolerance and those who did not were compared.
Results: One-year liver graft survival rates for adult and pediatric cases were 90.4% and 91.9%, respectively; the 5-year rates were 83.1% and 89.2%, respectively; the 10-year rates were 79.7% and 89.2%, respectively; and 15-year rates were 65.9% and 83.8%, respectively. For the grafts that survived more than one year, the 10-year rates for adult and pediatric cases were 88.2% and 97.0%, respectively. The 10-year rates for adult LDLT in 0 mismatches, 1-2 mismatches, 3-4 mismatches, and 5-6 mismatches were 79.2%, 86.8%, 77.4%, and 69.4%, respectively. Although the survival rates were not significantly different, the survival rates were lowest in LDLT recipients with 5-6 HLA mismatches. Ten-year liver graft survival rates for adult LDLT with negative T-cell crossmatch, and positive T-cell crossmatch were 80.0% and 71.1%, respectively. The 1-year liver graft survival rates for adult LDLT with negative B-cell crossmatch, and positive B-cell crossmatch were 90.6% and 88.2%, respectively. None of the factors--age of recipients and donors, primary disease, donor gender, relationship of donors to recipients, positive crossmatches, or number of HLA mismatches--was significantly different between COT and non-COT recipients, except for recipient gender (p = 0.01); in COT cases, there were more female recipients (88.9%) than male (11.1%). Post-transplant complications--acute rejection rate in one year post-transplant, biliary complications rate, and vascular complication rate--were not significantly different between COT and non-COT recipients.
Conclusions: High long-term survival was achieved by both adult and pediatric recipients. Even higher survival can be achieved by improving early graft loss. Further studies are necessary to determine the impact of HLA mismatches and positive crossmatches on long-term outcomes and tolerance.
Similar articles
-
Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.Clin Transpl. 2011:1-16. Clin Transpl. 2011. PMID: 22755397
-
Implications of a positive crossmatch in liver transplantation: a 20-year review.Liver Transpl. 2012 Apr;18(4):455-60. doi: 10.1002/lt.22474. Liver Transpl. 2012. PMID: 22139972
-
A multi-factor analysis of kidney regraft outcomes.Clin Transpl. 2002:335-49. Clin Transpl. 2002. PMID: 12971460
-
The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients.Clin Transpl. 2014:131-6. Clin Transpl. 2014. PMID: 26281137 Review.
-
Recent developments in desensitization of crossmatch-positive kidney transplant recipients.Transplant Proc. 2012 Jul-Aug;44(6):1648-51. doi: 10.1016/j.transproceed.2012.04.006. Transplant Proc. 2012. PMID: 22841236 Review.
Cited by
-
A network-based approach to identify expression modules underlying rejection in pediatric liver transplantation.Cell Rep Med. 2022 Apr 19;3(4):100605. doi: 10.1016/j.xcrm.2022.100605. eCollection 2022 Apr 19. Cell Rep Med. 2022. PMID: 35492246 Free PMC article.
-
Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.Transplant Direct. 2021 Jul 16;7(8):e729. doi: 10.1097/TXD.0000000000001180. eCollection 2021 Aug. Transplant Direct. 2021. PMID: 34291151 Free PMC article.
-
A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.Turk J Med Sci. 2021 Apr 30;51(2):610-622. doi: 10.3906/sag-2007-82. Turk J Med Sci. 2021. PMID: 33037873 Free PMC article.
-
Liver Transplantation for Patients with Cholestatic Liver Diseases.Viszeralmedizin. 2015 Jun;31(3):194-8. doi: 10.1159/000431017. Epub 2015 Jun 8. Viszeralmedizin. 2015. PMID: 26468315 Free PMC article. Review.
-
Outcomes in liver transplantation: does sex matter?J Hepatol. 2015 Apr;62(4):946-55. doi: 10.1016/j.jhep.2014.11.023. Epub 2014 Nov 27. J Hepatol. 2015. PMID: 25433162 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous